Gene Editing Market Analysis by top key players CRISPR Therapeutics, Addgene, Allele Biotech, Bio-Rad, Takara Bio, DNA2.0, Integrated DNA Technologies
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467840/?utm_source=OPR.com-SP
U.S. gene editing market will witness 14.5% CAGR by 2024 owing to increasing funding for research and development in genetic editing technologies. As per National Center for Advancing Translational Sciences 2018 report, National Institute of Health (NIH) got $86 million funding for improving genome editing techniques. Moreover, rising prevalence of Alzheimer, cancer and infectious diseases in country. As per Alzheimer's association 2018 report, an estimated 5.7 million Americans of all ages are living with Alzheimer's. Increasing patient preference towards advanced gene editing tools such as CRISPR/Cas9 for the treatment of Alzheimer's should drive gene editing business expansion.
The global gene editing market share is projected to gain sizeable returns over the coming years owing to increased funding toward genetics research coupled with the emergence of CRISPR technology in the food industry.
China gene editing market was valued at USD 154.6 million in 2017 and is estimated to experience considerable growth due to rising R&D expenditure and growing number of industry players. Moreover, various initiatives taken by the Chinese government for promoting life science research in biotechnology sector will stimulate gene editing market growth in forthcoming years.
Research institutes segment accounted for 30.2% revenue share in 2017 owing to increasing focus on developing innovative therapeutics models in CRISPR and ZFN. Moreover, growing incidences of rare genetic diseases has resulted in high demand for research activities for developing new therapies will propel segmental growth over the coming years.
Animal genetic engineering segment was valued at USD 785.4 million in 2017 and is projected to grow significantly over the forecast timeframe. Growing applications of products obtained from domestic animals has boosted the demand for gene editing technique. In addition, wide applicability of these techniques in animal genetic engineering is also a contributing factor for business growth. For instance, Pigs are susceptible to an infection called Porcine Reproductive and Respiratory Syndrome (PRRS). Gene editing techniques have managed to produce pigs that are resistance to this disease.
Zinc Finger Nucleases (ZFNs) segment will witness 14.5% CAGR from 2018 to 2024. The segment growth is attributed to increasing adoption of these advanced gene editing tools in research institutes and biotech industries. ZFNs technology offers various advantages including, the mutations made by this technology are permeant and heritable. Zinc finger nucleases are useful to manipulate the genomes of many plants and animals and also has important role in gene editing processes.
Gene Editing Market will exceed USD 7.5 billion by 2024; as per a new research report. Rising prevalence of cancer and other genetic disorders coupled with increasing demand for personalized medicine should stimulate gene editing industry expansion. As per WHO 2018 report, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths. Increasing use of the gene editing tools for treatment of these chronic disorders will favor business growth. Moreover, increased government funding programs will significantly impact industry growth over the forecast timeframe.
Some of the prominent competitors operating in gene editing market include Addgene, Allele Biotech, Bio-Rad, Takara Bio, CRISPR Therapeutics, DNA 2.0, Editas Medicine, Intellia Therapeutics, Integrated DNA Technologies, Juno Therapeutics, OriGene Technologies, Promega, Precision Biosciences and Recombinetics. Industry competitors are mainly focusing on inorganic strategies such as partnership, merger and acquisitions to escalate their market position as well as strengthen product offerings.
Table of Content:
Chapter 1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
184.108.40.206. Paid sources
220.127.116.11. Unpaid sources
Chapter 2. Executive Summary
2.1. Gene editing industry 360 degree synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Application trends
2.1.3. Technology trends
2.1.4. End-user trends
2.1.5. Regional trends
Chapter 3. Gene Editing Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
18.104.22.168. Increased funding for genetic research in North America
22.214.171.124. Increased R&D expenditure and growth of biotechnology sector in Europe
126.96.36.199. Increasing demand for synthetic genes in Asia Pacific and North America
188.8.131.52. Technological advancements in gene editing in North America
3.3.2. Industry pitfalls and challenges
184.108.40.206. Stringent government regulations
220.127.116.11. Lack of public awareness in developing and underdeveloped regions
3.4. Growth potential analysis
3.4.1. By application
3.4.2. By technology
3.4.3. By end-user
3.5. Competitive landscape, 2017
3.5.1. Strategy dashboard
3.6. Porter's analysis
3.7. PESTEL analysis
Chapter 4. Gene Editing Market, By Application
4.1. Key segment trends
4.2. Cell line engineering
4.2.1. Market size, by region, 2013-2024 (USD Million)
4.3. Animal genetic engineering
4.3.1. Market size, by region, 2013-2024 (USD Million)
4.4. Plant genetic engineering
4.4.1. Market size, by region, 2013-2024 (USD Million)
4.5. Other applications
4.5.1. Market size, by region, 2013-2024 (USD Million)
Chapter 5. Gene Editing Market, By Technology
5.1. Key segment trends
5.2.1. Market size, by region, 2013-2024 (USD Million)
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467840/?utm_source=reportsgo.com-SP
Global Gene Editing Technologies Market Size, Status and Forecast 2019-2025
Genome editing is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism.
In 2018, the global Gene Editing Technologies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
Read more at: https://www.marketwatch.com/press-release/downhole-tools-market-size-rising-at-more-than-45-cagr-during-2019-2025-analysis-of-key-players-trends-drivers-2019-08-06
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
US Toll Free: 1-866-764-2150
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene Editing Market Analysis by top key players CRISPR Therapeutics, Addgene, Allele Biotech, Bio-Rad, Takara Bio, DNA2.0, Integrated DNA Technologies here
News-ID: 1979161 • Views: 702
More Releases from marketstudyreport.com
Covid -19 Impact on Video Conferencing Market Size 2026: Top Companies, Trends a …
Market Study Report recently introduced new title on “2020-2026 Global Video Conferencing Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates Market size outlook and status to 2026. Video Conferencing Market size is anticipated to grow at over 19% CAGR between 2020 and 2026. The global video conferencing market is set to register a tremendous rise in its growth
What's driving the Patient Monitoring Devices Market Size? Fukuda, Philips, Skan …
Selbyville, Delaware the prime objective of Patient Monitoring Devices report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. Wireless segment is anticipated to witness more than 5% growth over the forecast period. Substantial growth can be attributed to rising preference for
What's driving the 3D Implants Market trends? Stryker, Smith and Nephew, DJO Glo …
The 3D Implants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Request a sample Report of 3D Implants Market at: https://www.marketstudyreport.com/request-a-sample/2679238/?utm_source=OPR.com/&utm_medium=SP The most likely (base case) scenario
Artificial Vascular Implants Market is thriving worldwide by 2025 | Top Key Play …
Global Artificial Vascular Implants Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Artificial Vascular Implants Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Artificial Vascular Implants market and provides information regarding the revenue for the period 2020 to 2025. The Artificial Vascular Implants market report provides
More Releases for Gene
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Gene Synthesis Market Size 2017-2022 OriGene, Gene Oracle, Genescript
e Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded
Gene Therapy Drug Pipeline Analysis
“Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight
Cancer Gene Therapy Market Analysis
The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer. The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant
Global Gene Editing Technologies Market
Gene editing with engineered nucleases is anticipated to contribute significantly to the global life sciences industry. Gene editing provides application from studying gene functions in plants and animals to gene therapy in humans. Gene editing has more efficiency than many other methods in reverse genetics. Increased development of genetic engineering and increased funding in the field of gene editing is anticipated to drive the growth of the global gene editing